Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoCirc-001 dobutamine neonatal formulation trial for haemodynamic insufficiency
2013-002845-12Phase 2Recruiting
- Sponsor
- SERMAS
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of dobutamine in Cardiovascular collapse (2 arms), sponsored by SERMAS. Primary endpoints: Composite failure endpoint and Death or worst cranial ultrasound appearance. Started Nov 2013; status: recruiting.
02
Drugs
dobutamine
03
Conditions
Cardiovascular collapse
Beyond the preview
Go deeper on 2013-002845-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002845-12.